Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

BACKGROUND: Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by compari...

Full description

Saved in:
Bibliographic Details
Published in:BMC Pharmacol Toxicol
Main Authors: Chamoun, Nibal, Ghanem, Hady, Hachem, Ahmad, Hariri, Essa, Lteif, Christelle, Mansour, Hanine, Dimassi, Hani, Zalloum, Richard, Ghanem, Georges
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505244/
https://ncbi.nlm.nih.gov/pubmed/31064405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0308-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items